Ricardo Cubedo

1.9k total citations
50 papers, 1.1k citations indexed

About

Ricardo Cubedo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Ricardo Cubedo has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 10 papers in Gastroenterology. Recurrent topics in Ricardo Cubedo's work include Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (10 papers) and Gastrointestinal Tumor Research and Treatment (10 papers). Ricardo Cubedo is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (10 papers) and Gastrointestinal Tumor Research and Treatment (10 papers). Ricardo Cubedo collaborates with scholars based in Spain, Switzerland and United States. Ricardo Cubedo's co-authors include Xavier García del Muro, Javier Martín‐Broto, Andrés Poveda, Antonio López–Pousa, Claudia Valverde, Javier Martínez‐Trufero, José Antonio López‐Guerrero, Joan Maurel, Virginia Martínez and Ignacio Romero and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Ricardo Cubedo

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ricardo Cubedo Spain	14	637	566	223	196	186	50	1.1k
Mesut Şeker Türkiye	17	488 0.8×	615 1.1×	410 1.8×	92 0.5×	66 0.4×	98	1.3k
Bala Başak Öven Ustaalıoğlu Türkiye	16	433 0.7×	523 0.9×	365 1.6×	110 0.6×	48 0.3×	83	1.1k
Gianluca Russo Italy	21	440 0.7×	354 0.6×	521 2.3×	77 0.4×	58 0.3×	82	1.2k
Fatih Selçukbırıcık Türkiye	16	342 0.5×	246 0.4×	247 1.1×	69 0.4×	44 0.2×	93	761
Paolo Aurello Italy	22	642 1.0×	644 1.1×	751 3.4×	143 0.7×	41 0.2×	102	1.3k
Yukiyoshi Esaki Japan	20	358 0.6×	569 1.0×	607 2.7×	126 0.6×	36 0.2×	52	1.3k
Seong Yoon Yi South Korea	22	466 0.7×	487 0.9×	301 1.3×	48 0.2×	80 0.4×	70	1.2k
Shoichi Fujii Japan	25	755 1.2×	1.1k 2.0×	1.1k 4.7×	261 1.3×	125 0.7×	101	1.8k
Francesco Stipa Italy	21	358 0.6×	680 1.2×	944 4.2×	102 0.5×	58 0.3×	69	1.4k
Sylvain Causeret France	15	471 0.7×	487 0.9×	363 1.6×	28 0.1×	198 1.1×	33	1.0k

Countries citing papers authored by Ricardo Cubedo

Since Specialization

Citations

This map shows the geographic impact of Ricardo Cubedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Cubedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Cubedo more than expected).

Fields of papers citing papers by Ricardo Cubedo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Cubedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Cubedo. The network helps show where Ricardo Cubedo may publish in the future.

Co-authorship network of co-authors of Ricardo Cubedo

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Cubedo. A scholar is included among the top collaborators of Ricardo Cubedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Cubedo. Ricardo Cubedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torres-Jiménez, Javier, Mariano Ponz‐Sarvisé, Bruno Bockorny, et al.. (2025). First-in-human phase 1 dose escalation trial of OMTX705, a novel anti-fibroblast activation protein (FAP) antibody drug conjugate (ADC), in monotherapy and in combination with pembrolizumab in patients with solid tumors.. Journal of Clinical Oncology. 43(16_suppl). 3028–3028. 2 indexed citations

Razak, Albiruni R. Abdul, Sebastian Bauer, Cristina Suárez, et al.. (2021). Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study. Clinical Cancer Research. 28(6). 1087–1097. 43 indexed citations

Muro, Xavier García del, Joan Maurel, Javier Martínez‐Trufero, et al.. (2018). Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study. Investigational New Drugs. 36(3). 468–475. 14 indexed citations

Martín-Liberal, Juan, Antonio López–Pousa, Javier Martínez‐Trufero, et al.. (2017). Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study. Targeted Oncology. 13(1). 81–87. 9 indexed citations

Isla, Alberto, et al.. (2015). Primary Epidural Lumbar Ewing Sarcoma. Spine. 41(6). E375–E378. 3 indexed citations

López‐Tarruella, Sara, Yolanda Jerez, Iván Márquez‐Rodas, et al.. (2015). Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial. Breast Cancer Research and Treatment. 153(2). 371–382. 79 indexed citations

Martín‐Broto, Javier, Silvia Calabuig‐Fariñas, Antonio Gutiérrez, et al.. (2014). Integrating Genotype in Risk Classification for Gist Recurrence. a Spanish Group for Sarcoma Research (Geis) Study. Annals of Oncology. 25. iv495–iv495. 2 indexed citations

Rasilla, J. Mucientes, et al.. (2014). 18F-FDG–PET–CT in soft tissue sarcomas: When to image?. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 33(1). 43–49. 7 indexed citations

Rasilla, J. Mucientes, et al.. (2013). 18F-FDG-PET-TC en sarcomas de partes blandas: ¿cuándo?. Revista Española de Medicina Nuclear e Imagen Molecular. 33(1). 43–49. 12 indexed citations

10.

Martín‐Broto, Javier, Xavier García del Muro, Antonio López–Pousa, et al.. (2012). Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study. Annals of Oncology. 23. ix490–ix490. 1 indexed citations

11.

Muro, Xavier García del, Antonio López–Pousa, Joan Maurel, et al.. (2011). Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study. Journal of Clinical Oncology. 29(18). 2528–2533. 197 indexed citations

12.

Muro, Xavier García del, Javier Martı́n, Joan Maurel, et al.. (2011). Guía de práctica clínica en los sarcomas de partes blandas. Medicina Clínica. 136(9). 408.e1–408.e18. 10 indexed citations

13.

Martín‐Broto, Javier, Xavier García del Muro, A Gutiérrez, et al.. (2011). KIT, DOG1, PDGFR, and IGFR1 gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.. Journal of Clinical Oncology. 29(15_suppl). 10047–10047.

14.

López–Pousa, Antonio, Binh Bui Nguyen, Xavier García del Muro, et al.. (2011). A phase II study of a new formulation of nonpegylated liposomal doxorubicin (doxorubicin GP-pharm) as first-line treatment in patients with advanced soft-tissue sarcomas (STS) who are age 65 or older: A GEIS trial.. Journal of Clinical Oncology. 29(15_suppl). 10072–10072. 5 indexed citations

15.

Martín, Andrés J. Muñoz, et al.. (2011). SEOM guidelines on thrombosis in cancer patients. Clinical & Translational Oncology. 13(8). 592–596. 5 indexed citations

16.

Maurel, Joan, Ana Sofia Martins, Andrés Poveda, et al.. (2010). Imatinib plus low‐dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high‐dose imatinib. Cancer. 116(15). 3692–3701. 28 indexed citations

17.

Paz‐Ares, Luis, Eduardo Díaz‐Rubio, Margarita García, et al.. (2007). Phase II Study of Trabectedin in Pretreated Patients with Advanced Colorectal Cancer. Clinical Colorectal Cancer. 6(7). 522–528. 10 indexed citations

18.

López, Ana, Ricardo Cubedo, Daniel Castellano, et al.. (2005). Phase I trial of the sequential administration of pemetrexed (P) and docetaxel (D) in patients (pts) with advanced solid tumours. Journal of Clinical Oncology. 23(16_suppl). 2108–2108. 4 indexed citations

19.

Lleonart, Matilde E., José Manuel García, Mariano Provencio, et al.. (1998). Loss of Heterozygosity in the Region Including the BRCA1 Gene on 17q in Colon Cancer. Cancer Genetics and Cytogenetics. 104(2). 119–123. 37 indexed citations

20.

Mayordomo, José, Fernando Rivera, P. Lianes, et al.. (1995). Improving Treatment of Chemotherapy-Induced Neutropenic Fever by Administration of Colony-Stimulating Factors. JNCI Journal of the National Cancer Institute. 87(11). 803–808. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact